|
DTWD1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
1.67780012105823E-10 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62436730732907E-12 |
| Stage1-vs-Stage2 |
4.932800E-01 |
| Stage1-vs-Stage3 |
1.062820E-01 |
| Stage1-vs-Stage4 |
2.845300E-04 |
| Stage2-vs-Stage3 |
1.273050E-01 |
| Stage2-vs-Stage4 |
5.103600E-03 |
| Stage3-vs-Stage4 |
8.112200E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
7.00820002030866E-09 |
| Normal-vs-Asian |
5.90971716007971E-12 |
| Caucasian-vs-AfricanAmerican |
5.333200E-01 |
| Caucasian-vs-Asian |
1.778610E-01 |
| AfricanAmerican-vs-Asian |
7.399400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
6.738400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62492241884138E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(81-100Yrs) |
3.98690000014135E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.752200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.718200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.949230E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.911600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.308600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.545800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.040600E-04 |
| Classical-VS-Follicular |
5.115300E-03 |
| Classical-VS-Other |
6.585400E-01 |
| Classical-VS-Normal |
1.62747593179802E-12 |
| Tall-VS-Follicular |
1.79919999998557E-06 |
| Tall-VS-Other |
2.029400E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
7.313600E-01 |
| Follicular-VS-Normal |
1.88160043101959E-10 |
| Other-VS-Normal |
1.936330E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
2.202400E-02 |
|
|
